Abstract: The present invention relates to the use of binding partners for 5-HT5 receptors for the treatment of neuropathological, in particular neurodegenerative and/or neuropsychiatric, disorders, which can occur, in particular, in cerebral ischemia, stroke, epilepsy and seizures in general, chronic schizophrenia, other psychotic disorders, dementia, in particular Alzheimer's dementia, demyelinizing disorders, in particular multiple sclerosis, and brain tumors. The invention also relates to processes for the identification and characterization of such binding partners, in particular in the form of screening processes.

Abstract: Method and apparatus for drying wet bio-solids by utilizing waste heat from a clinker cooler in a cement making process.

Abstract: Method and apparatus for drying wet bio-solids by utilizing waste heat from a clinker cooler in a cement making process.

Abstract: Method and apparatus for drying wet bio-solids by utilizing waste heat from a clinker cooler in a cement making process.

Abstract: Method and apparatus for drying wet bio-solids by utilizing waste heat from one of a clinker cooler or kiln exhaust gases in a cement making process.

Abstract: Method and apparatus for drying wet bio-solids by utilizing waste heat from a clinker cooler in a cement making process.

Abstract: The present invention relates to the use of binding partners for 5-HT5 receptors for the treatment of neuropathological, in particular neurodegenerative and/or neuropsychiatric, disorders, which can occur, in particular, in cerebral ischemia, stroke, epilepsy and seizures in general, chronic schizophrenia, other psychotic disorders, dementia, in particular Alzheimer's dementia, demyelinizing disorders, in particular multiple sclerosis, and brain tumors. The invention also relates to processes for the identification and characterization of such binding partners, in particular in the form of screening processes.

Abstract: Compounds of the formula I 1

Abstract: The invention relates to the use of binding partners for 5-HT5-receptors in the treatment of neuropathological and in particular neurodegenerative and/or neuropsychiatric disturbances which can occur notably in cases of cerebral ishcemia, cerebral stroke, epilepsy and attacks in general, chronic schizophrenia, other psychotic illnesses, dementia, notably Alzheimer's disease, demyelination diseases, notably multiple sclerosis and brain tumors. The invention also relates to methods, especially screening methods, for identifying and characterizing such binding partners.

Abstract: Use of pyrimidine derivatives of the formula I where the substituents are as defined in the description, and of their physiologically tolerated salts for producing medicaments for the prophylaxis and treatment of cerebral ischemia and strokes.

Abstract: Pyrrolylquinoxalinediones of the formula I and their tautomeric and isomeric forms, and their physiologically tolerated salts are described, where the variables have the following meaning: R1 hydrogen, C1-C6-alkyl, substituted by hydroxyl or carboxyl, R2 hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a chlorine, fluorine or bromine atom, a trihalomethyl, cyano or nitro group or SO2—C1-C4-alkyl, R3 COOH or a radical which can be hydrolyzed to the carboxyl group, n 1 or 2.

Abstract: To implement a radio system (PRS) for a closed user group by simple means and at low cost, a device (MONE) is proposed which connects at least one commercially available base station (BTS1, BTS2) to a telecommunication network (PSTN) via standard interfaces (PCM30, Abis). The device comprises a subscriber data base (ID) and means (MM) for checking whether a transmitted subscriber identification (IMSI) authorizes a subscriber to access the radio system (PRS). The device further controls the establishment and release of calls (CC) and performs radio resource management functions (RR). A radiotelephone (MS) authorized to access the radio system (PRS) is connected to the nearest base station (BTS1) at least for the duration of the call.

Abstract: Universal data input card which loads the data of a destination point and the route into the navigation device. The card can be produced completely by printing and can be published in any printed product. On the card is a picture field (3) to locate a photo and text field (4) for locating text information, miniature map segments (2) which contain the route information and a bar-code (1) which provides the coordinates of the destination points. The card of the selected destination point is simply inserted into a card input slot (7) of a GPS device which is built together with an optoelectronic card reader. The device then navigates the driver to the destination point by means of the information shown on a display (6) which can be accompanied by additional voice information. The purpose of introducing the system which operates with a printed card is to spread GPS technology into everyday use for the public.

Abstract: SAMe and its physiologically tolerated salts are administered to a patient for the treatment of reperfusion damage caused by temporary focal ischemia.

Abstract: A radio system, particularly a mobile radio system (MRS) is proposed, which has radio interfaces (COMa) with variable parameters (Ta, Fa), which are predetermined and changed by the base station BS. The parameters are computed in the base station on the basis of a requested transmission capacity (CAPr) desired by a remote radio station (MSa), and on the basis of the determination of free transmission capacities (CAPl) within a specified frequency range. The parameters (Ta, Fa) for adjusting the transceivers in the base station and in the remote radio stations are predetermined in such a way, that the desired transmission capacity occupies the fewest possible of the free transmission capacities. An efficient utilization of the frequency spectrum is achieved, where the radio transmission continuously adapts to the capacity requirements of the mobile stations.

Abstract: A mobile test set for testing a mobile-radio system containing system components to be tested and at least one operation and maintenance center. The mobile test set has a first interface for the exchange of test signals between the mobile test set and at least one of the system components and a second interface for the exchange of control signals between the mobile test set and at least one man-machine interface. The two interfaces are linked so that the exchange of the control signals takes place via at least one of the system components between the mobile test set and at least one man-machine interface installed in the operation and maintenance center.

Abstract: Compounds of the formula ##STR1## where Ar, R.sup.1, R.sup.2, P and Q have the meanings indicated in the description, and the preparation thereof are described. The compounds have antihypoxic and antiischemic action and are suitable for treating acute and chronic degenerative processes of the CNS and other organs.

Abstract: 2-Hydroxy-3-phenoxy-propyl-substituted piperazines of the formula I ##STR1## in which R.sup.1 -R.sup.5, Y, m and n have the meaning indicated in the description, and the preparation thereof are described. The novel compounds are suitable for the therapy of oxygen deficiency diseases of the brain.

Abstract: 9-Amino-2-phenylbicyclo-[3.3.1]nonanes and 9-amino-2-phenylbicyclo[3.3.1]non-2-enes of the formula I ##STR1## where R.sup.1 and R.sup.2 are identical or different and each is hydrogen, halogen, alkyl, alkoxy, dialkylamino, trifluoromethyl, hydroxyl, alkylthio, alkylsulfonyl or nitro, R.sup.3 and R.sup.4 are identical or different and each is hydrogen, alkyl or 1 to 5 or alkenyl or alkynyl of 2 to 5 carbon atoms, or benzyl, it also being possible for R.sup.3 and R.sup.4 together to form a saturated chain which contains from three to seven carbon atoms and can be substituted by phenyl, and where is a single or double bond, are used for producing drugs which act, in particular, on the central nervous system.

Abstract: The use of (S)-emopamil and the salts thereof for the treatment of migraine is described.